News
People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...
Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a ...
58mon MSN
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
Eli Lilly › Eli Lilly (NYSE: LLY) has been a terrific stock to own over the past 15 years; it has consistently outperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results